Topics

Articles

Agreement focused on enhancing insights into the location and condition of temperature-sensitive drugs and vaccines, including ones for Covid-19

Deal bolsters ANI’s generics and CDMO portfolio

More than $600 million in backing opens the door for additional manufacturing capacity, further Covid-19 preparations

Company’s rebranded platform, Ocellos, will manage complex handoffs in cell and gene therapy (CGT) treatments and trials

Agreements to focus on driving adoption of AI and natural language processing for medical affairs programs

The 130,000-square-foot site will be the CDMO's third location 

Partnership’s priority is to evaluate mental health medication

Marks the latest big pharma partnership for CureVac around its Covid vaccine candidate, CVnCoV

Drone technology delivers doses to difficult-to-reach locations